Stereotactic body radiotherapy with sintilimab and bevacizumab biosimilar in anti-PD-1 refractory hepatocellular carcinoma: the ReUNION-1 phase 2 trial
立体定向放射治疗联合信迪利单抗和贝伐单抗生物类似药治疗抗PD-1耐药性肝细胞癌:ReUNION-1 II期试验
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-67528-4
Tang, Jing; Yang, Yongqiang; Liu, Dongen; Wang, Bicheng; Lin, Zhenyu; Wu, Zilong; Zhang, Jinfeng; Zhang, Dejun; Liu, Yaqin; Ge, Minghui; Chen, Lei; Wu, Gang; Zhang, Tao; Xue, Jun